Stocks and Investing
Stocks and Investing
Thu, February 10, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, February 9, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Kaveri Pohlman Maintained (SONN) at Strong Buy on, Feb 9th, 2022
Kaveri Pohlman of BTIG, Maintained "Sonnet BioTherapeutics Holdings, Inc." (SONN) at Strong Buy on, Feb 9th, 2022.
Kaveri has made no other calls on SONN in the last 4 months.
There are 2 other peers that have a rating on SONN. Out of the 2 peers that are also analyzing SONN, 0 agree with Kaveri's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Kaveri
- Keay Nakae of "Chardan Capital" Maintained at Strong Buy on, Monday, December 20th, 2021
- Michael King of "HC Wainwright & Co." Initiated at Strong Buy on, Thursday, December 16th, 2021
Contributing Sources